Scientists have developed a new screening technique to identify high-performing biomaterials for encapsulating islet cells for Type 1 diabetes treatment. The technique uses a unique “barcode” to track each biomaterial formulation. The findings could lead to more sustainable, long-term, self-regulating treatments for Type 1 diabetes that do not require immunosuppression. (The multicolored beads illustrate the barcoded biomaterial capsules.)
